Clinical Trial Update: A Study of Low Dose Bevacizumab With Conventional Radiotherapy Alone in Diffuse Intrinsic Pontine Glioma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating low-dose bevacizumab with conventional radiotherapy for diffuse intrinsic pontine glioma. The study is currently in th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Intrinsic Pontine Glioma

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Tata Memorial Centre | Conditions: DIPG | Phase 2 | Status: RECRUITING